← Open Payments lookup

KAREEM NEAL: Open Payments

NPI 1669149795 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$647 in 30 payments from 9 companies in 2025. Trend: 2023 $368 · 2024 $260 · 2025 $647

Food & beverage: $647
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$273
Neurocrine BioSciences, Inc.4$111
E.R. Squibb & Sons, L.L.C.3$62
Otsuka America Pharmaceutical, Inc.2$60
Vanda Pharmaceuticals Inc.3$48
Braeburn Inc.2$33
Axsome Therapeutics, Inc.1$23
Exact Sciences Corporation1$20
Teva Pharmaceuticals USA, Inc.1$16

Products named: CAPLYTA, INGREZZA, COBENFY, REXULTI, FANAPT, BRIXADI, Auvelity, The Cologuard Plus Collection Kit.

Industry payments across LA — which companies pay providers there.